Next Article in Journal
Pertuzumab and Trastuzumab Combination with Concomitant Locoregional Radiotherapy for the Treatment of Breast Cancers with HER2 Receptor Overexpression
Next Article in Special Issue
Peripheral T-Cell Lymphomas: Therapeutic Approaches
Previous Article in Journal
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience
Previous Article in Special Issue
Peripheral T-Cell Lymphoma, Not Otherwise Specified: Clinical Manifestations, Diagnosis, and Future Treatment
 
 
Article

Article Versions Notes

Cancers 2021, 13(19), 4788; https://doi.org/10.3390/cancers13194788
Action Date Notes Link
article pdf uploaded. 24 September 2021 15:51 CEST Version of Record https://www.mdpi.com/2072-6694/13/19/4788/pdf-vor
article xml file uploaded 27 September 2021 06:06 CEST Original file -
article xml uploaded. 27 September 2021 06:06 CEST Update -
article pdf uploaded. 27 September 2021 06:06 CEST Updated version of record https://www.mdpi.com/2072-6694/13/19/4788/pdf-vor
article html file updated 27 September 2021 06:07 CEST Original file -
article xml file uploaded 1 October 2021 07:34 CEST Update -
article xml uploaded. 1 October 2021 07:34 CEST Update https://www.mdpi.com/2072-6694/13/19/4788/xml
article pdf uploaded. 1 October 2021 07:34 CEST Updated version of record https://www.mdpi.com/2072-6694/13/19/4788/pdf
article html file updated 1 October 2021 07:35 CEST Update -
article html file updated 30 July 2022 07:31 CEST Update https://www.mdpi.com/2072-6694/13/19/4788/html
Back to TopTop